In view of the broad significance of c-Myc in the etiology of human cancers and the impact of N-Myc and L-Myc in specific tumors like neuroblastoma and small cell lung cancer, the effectiveness of the pyridine inhibitors justifies further efforts to improve the pharmacokinetic and solubility properties. The gene discussed is MYCN; the disease is neuroblastoma.